X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-gets-4-observations-from-usfda-for-andhra-pradesh-facility/articleshow/111192847.cms
https://www.moneycontrol.com/news/business/companies/biocon-seeks-partner-to-test-generic-wegovy-ozempic-in-china-12752897.html
https://www.biocon.com/biocon-limited-signs-exclusive-licensing-and-supply-deal-for-the-commercialization-of-liraglutide-in-south-korea-with-handok-inc/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-biocon-units-biosimilar-blockbuster-eye-drug-eylea-2024-05-20/
https://economictimes.indiatimes.com/industry/healthcare/biotech/acceleration-of-biosimilar-business-debt-reduction-to-be-key-priorties-in-fy25-biocon-chief/articleshow/110217477.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-sun-cipla-and-biocon-look-to-recreate-ozempic-magic-in-india/articleshow/109653300.cms
https://www.indianpharmapost.com/news/biocon-receives-approval-from-sahpra-for-tacrolimus-capsule-15548
https://www.reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-partners-biomm-to-commercialise-diabetes-drug-in-brazil/articleshow/109379384.cms
Market Place
Share 
